psyche
Mania / Hypomania
Adverse effectMania / Hypomania is an adverse psyche-related outcome involving the occurrence of hypomania, mania, or a switch between them. In this context, it describes these outcomes as potentially caused by an intervention, rather than a beneficial effect.
Mania / Hypomania is a psyche-related topic presented in a clear, structured format.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Loving-Kindness Meditation (Metta)practiceUnclear
Based on one study. Strongest study: a randomized controlled trial.
A randomized trial involving 184 people with Anxiety Disorder (General) reported an inpatient psychiatric admission for bipolar mania.
Open the Loving-Kindness Meditation (Metta) pageFastingpracticeUnclear
Based on one study. Strongest study: a systematic review of studies.
A 2025 systematic review described psychotic or manic decompensations in relation to fasting; the finding did not quantify how often they occurred.
Open the Fasting pageMeditationpracticeUnclear
Based on one study. Strongest study: a narrative review.
A review of healthy participants described mania or psychosis in intensive retreat settings.
Open the Meditation pagePsychotherapypracticesimple.meter.userReports
Based on one study.
Open the Psychotherapy page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on4 listedHighest probability
- →PracticesLoving-Kindness Meditation (Metta)CertaintyLowSourceClinical1 other source
A randomized trial involving 184 people with Anxiety Disorder (General) reported an inpatient psychiatric admission for bipolar mania.
Who was studied
- People with a condition
- Anxiety Disorder
Open Loving-Kindness Meditation (Metta)Study result
inpatient psychiatric admission (bipolar mania)
- →PracticesFastingCertaintyLowSourceClinical1 other source
A 2025 systematic review described psychotic or manic decompensations in relation to fasting; the finding did not quantify how often they occurred.
Open FastingStudy result
Psychotic or manic decompensations
- →PracticesMeditationCertaintyLowSourceReview1 other source
A review of healthy participants described mania or psychosis in intensive retreat settings.
Who was studied
- Healthy people
Open MeditationStudy result
Mania or psychosis (in intensive retreat settings)
- →PracticesPsychotherapyCertaintyLowSourceAnecdotal1 other source
This effect was mentioned in 2 of 219 Reddit reports discussing it.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Mania / Hypomania is an adverse psyche-related outcome involving the occurrence of hypomania, mania, or a switch between them. In this context, it describes these outcomes as potentially caused by an intervention, rather than a beneficial effect. Examples of interventions linked with this topic include Saffron Extract, Creatine, SAM-e, and St. John’s Wort.
How interventions help
For Mania / Hypomania, the interventions represented here are potential triggers rather than treatments. The pattern spans products associated with antidepressant or mood-elevating effects, serotonergic precursor use, and stimulation or sleep loss. These pathways may be especially relevant for people with bipolar-spectrum conditions or other susceptibility to mood elevation.
The practical concern is not limited to a single product category. Mood changes have been described with some antidepressant-oriented supplements, while caffeine-related sleep loss may precipitate symptoms in susceptible people. Reports also describe possible mood elevation when certain products are combined with antidepressants, making the broader context of use important rather than considering an intervention in isolation.
The strength and detail of the findings vary substantially. Some are supported by clinical research or reviews, while others come from pharmacology references, case-level observations, or anecdotal reports that cannot establish causality or identify specific risk factors. The available information does not establish a consistent dose, onset timeline, duration of use, or persistence after stopping across these interventions. New or worsening decreased need for sleep, racing thoughts, irritability, or unusually elevated mood warrants attention, particularly in people with a bipolar-spectrum history.
Choosing guidance
When choosing among these options, first consider whether there is a personal susceptibility to mania or hypomania, including a bipolar-spectrum history or previous mood elevation after supplements or antidepressants. Several entries describe possible mood activation in susceptible people, so an option that appears suitable for another purpose may not be a neutral choice in this context.
The evidence is not equally direct. Some options have been examined in clinical research, while others are supported mainly by pharmacology references or anecdotal reports. Clinical evidence can still vary in depth, from broader evidence syntheses to a single study or review, so the type of evidence matters alongside the displayed probability. Reports and reference-based concerns can identify a possible signal, but they provide less information about how consistently it occurs or which circumstances increase risk.
No dose, duration, or onset information is provided here that would allow a reliable comparison of how much could be taken, how long use might continue, or how quickly mood changes might appear. The available entries also do not establish a consistent pattern of disagreement between studies. For someone with bipolar-spectrum illness, a predisposition to mania, or prior episodes of reduced sleep need, racing thoughts, irritability, or mood elevation, options associated with this effect warrant particular caution and discussion with a qualified clinician before use. For others, the distinction between clinical evidence and less direct reports is the most useful basis for comparing the listed options.